Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy. (2013)

First Author: Mitrpant C

Attributed to: MICA: MRC Centre for Neuromuscular Diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0062114

PubMed Identifier: 23630626

Publication URI: http://europepmc.org/abstract/MED/23630626

Type: Journal Article/Review

Volume: 8

Parent Publication: PloS one

Issue: 4

ISSN: 1932-6203